• 2022-2023 : Great networking opportunity`

    Beckers Kelly - Janssen-Cilag NV
  • 2022-2023: The course covers really interesting topics to better understand the Belgian healthcare landscape, with input from speakers with different perspectives. Next to that, the bond you create with your fellow attendees is really unexceptional.

    De Wilder Sigrid - Roche
  • 2022-2023: A great experience that allows you to learn from different stakeholders across the BE landscape while engaging with top-level speakers and colleagues/friends from other companies

    Elsen Aldo - Boehringer Ingelheim
  • 2022-2023: Met amazing people, learned new things even though learning can sometimes make you feel ´stupid´. At the end of the day it was fruitful because you are richer for it now.

    Embrechts Laura - Pfizer
  • 2022-2023: Great opportunity to get a 360° view of pharma industry and connect with peers

    Muniger Marisa - Sanofi
  • 2022-2023: Very refreshing, comforting and above all so pleasant to have been to IFB. And I am very happy that from now on, I actually am a part of the network :-)

    Meeus Ellyne - Kava
  • 2022-2023: Great content, great people, great discussions: overall, great experience

    Poedts Laurens - Abbvie
  • 2022-2023: Very solid program with industry-leading speakers and great opportunity to connect and meet new people.

    Reyniers Lauran - AstraZeneca
  • 2022-2023: IFB brings together inspiring speakers and engaging participants Together reflecting on the past, and building the future of the healthcare industry in Belgium and beyond. The network brings personal and professional joy

    Schelpe An-Sofie - MSD
  • 2022-2023: The course is one of a kind. An opportunity to enlarge your scope on the Belgian healthcare system and stakeholders. The element that pleased me the most is the fact that for every topic, IFB manages to invite the most important/biggest reference speaker

    Theuwis Jan - Eli Lilly
  • 2022-2023: Generation H(ealth) - the young high potential managers in Health of today will be the Health Business leaders of tomorrow. ;-)

    Van Den Branden Marie-France - Iqvia
  • 2022-2023: Inspiring, great networking opportunity & glad to know 30+ more colleagues in pharma

    Van den Daele Bart - Gilead
  • 2022-2023: One of the features of this course is its ability to provide participants with a comprehensive view of the healthcare landscape in Belgium. The diverse range of topics covered during the session ensures that attendees gain a well-rounded understanding

    Vande Ginste Marie - pharma.be
  • 2022-2023: Inspiring, Fruitful, Beyond unforgettable experience

    Vanmeerhaeghe Marthe - Bayer SA-NV
  • 2022-2023: ´This course is an opportunity for professional growth, offering essential industry insights and fostering valuable connections.´

    Bartholomé Manu - SA Goodlife Pharma NV
  • 2021-2022: ‘So happy to be part of the IFB Network. Looking back on a IFB year where I did not only had the opportunity to have a good overview on different aspects in healthcare, but also where I met great and fantastic people. Looking forward to future network events and to keep connected Thank You’

    Sofie De Mol – Iqvia
  • 2021-2022: ‘The IFB Course offers an excellent opportunity, not only to gain insights on how the Belgian Healthcare system works, but also to connect with an interesting group of new people with very diverse background. Definitely would recommend’

    Chana Nauwelaerts – Boehringer Ingelheim
  • 2021-2022 : ‘IFB Brings you through a journey across the Belgian healthcare landscape, and offers the opportunity to extend your network. Admirably, IFB gathers bothe the payors and the industry creating mutual awareness on needs and drivers.’

    Rodolphe Janssens – Gilead Sciences
  • 2021-2022: ‘As announced at the start, an intellectual holiday, something to look forward each month to connect with colleagues and broaden my view and knowledge of the healthcare ecosystem and their stakeholders.’

    Valerie Pauwels – Gilead Sciences
  • 2021-2022: ‘This is an ideal course for newcomers in the healthcare sector. The speakers are top-level and the quality of the interaction within the group is extremely valuable. Without any doubt, a very enriching experience.’

    Daxhelet Jean-Yves – MSD
  • 2021-2022: ‘IFB gave me the opportunity to a kick-start of building my own network in the healthcare sector. Due to the broad program of the course you always have a relevant topic to start a conversation.’

    Janne Schepers – Roche
  • 2021-2022: ‘The course provided a 360° tour of the Belgian healthcare landscape with highly skilled speakers. The angle of the looking at the future and reinforcing the feeling that all of us can play a role in shaping it was very refreshing. Congratulations for the smooth organization and see you soon IFB-ers’

    Hanne Wouters – pharma.be
  • 2021-2022: ‘This course is a perfect door opener in two aspects : first of all, it offers an overview of the different players in the pharmaceutical sector (and their points of view) and the challenges for the future. Secondly, it provides a huge expansion of the network. The combination of both is extremely motivating and challenged me to think more broadly.

    Siska Haers – Hebias
  • 2021-2022: ‘A big thank you Marine and Dirk for the great organisation. I was the first SOBI employee to participate and it will definitely not be the last one’

    Nicolas Dejaeger – SOBI
  • 2021-2022: ‘Een fantastische opportuniteit om het Belgische gezondheidszorgsysteem en de verschillende stakeholders beter te leren kennen, een nog betere ervaring.’

    Ilse Camps – RIZIV
  • 2021-2022: ‘Probably the best course in the Benelux to get in a very comprehensive way an insight in the industry, the stakeholders and the interfaces.’

    Tom De Gres – Solvus Health
  • 2021-2022: ‘Great network experience’

    Eveline Vanderheeren – Amgen
  • 2021-2022: ‘This course give a great overview of the pharmaceutical industry and creates the opportunity to meet very interesting people. An unique network is created during this 8 months.’

    Louis Roggen – Arega Pharma
  • 2021-2022: ‘This course was interesting, but more importantly, also fine It did not only allow me to learn and to thin ‘out-of-the-box’, but also to meet new people and even visit other companies. Thanks to these sessions, we were up to date and challenged tho think radically differently. Keep up these good courses

    Herteleer Liesbet – Roche
  • 2021-2022: ‘As a person with a non-pharmaceutical background, this course was really enriching and a real added value. Furthermore it was good to see that all participants, speakers were passionate about their work and always kept the patient in mind. I can sate that I’ve made friends for life after this course. For that I’m truly grateful.’

    Yannick Apers – MSD
  • 2021-2022: ‘An inspiring journey through the Belgian healthcare system, driven by speakers from different perspectives and fueled by the exchange between the participants and speakers allowing to highlight opportunities and challenges for the future.’

    Vandersmissen Ine – Janssen-Cilag
  • 2021-2022: ‘What a great experience The best networking opportunity, the best group of IFB’ers and this combined with a great overview of the healthcare landscape, explained by top speakers.’

    Berger Julie – Janssen-Cilag
  • 2020-2021: ‘There is no other formation that offers such a complete overview of our healthcare system… and you’re still learning after the formation thanks to newly-made connection’

    Sebastien Therville – RIZIV/INAMI
  • 2020-2021: ‘The IFB course gave a very complete view of the healthcare system, the challenges and opportunities, which is of high value in my daily job in communication. I met great people and appreciated their openness and interest in getting to know each other’

    Perrine Sokal – Abbvie
  • 2020-2021: ‘A pleasant deep-dive in the different facets of the health care system per course, alternated with mind-opening discussions among new friends in the healthcare field under a cup of coffee or a glass of wine/beer’

    Sarah Vanrenterghem – Novitan
  • 2020-2021: ‘This IFB course has a very good helicopter view of the Healthcare system as well as from several good speakers an idea of what will have to change and be taken into account in the future. The course makes you think with all the ‘baggage’ you have received. The networking that is linked to it is super Very happy that I now belong to the IFB club’

    An Verleye – Iqvia
  • 2020-2021: ‘This journey offers you a global overview and great insights on the Belgian Healthcare, with a fantastic opportunity to get together with participants each with very interesting background’

    Bruno Mortier – Febelco
  • 2020-2021: ‘Pilot-made healthcare courses and pharma meet-and-greets that benefit you knowledge and your well-being’

    Paul Nagels – Abbvie
  • 2019-2020: ‘The healthcare network HUB in Belgium, enriched by experienced perspectives from all stakeholders’

    Stefano Losi – Celgene
  • 2019-2020: ‘I’ve had the opportunity to participate as a speaker and as a jury member in the past. I’m glad I was give the opportunity to be a participant and become an IFBer now. The course was very interesting, the subjects discussed and the speaker helps everyone involved in health to think to the future. The many networking opportunities are a real plus’

    Vinciane Knappenberg – RIZIV/INAMI
  • 2019-2020: ‘The IFB training offered me a unique opportunity to learn more and better understand the pharma world and its dynamics and at the same time the possibility to connect with people from other companies. I really like the atmosphere and the links we created between us’

    Anais Junon – Pfizer
  • 2019-2020: ‘IFB Management course provides a great 360° overview of the Belgian healthcare landscape, with very interesting discussions and points of view of different stakeholders. In addition, it is a great networking platform’

    Maxime Allard - Pfizer
  • 2019-2020: ‘A mix of interesting topics across the entire healthcare ecosystem, brought in a high level manner by the most important actors, each showcasing their point of view, and a nice network opportunity, all glued together by two experienced hosts.’

    Pieter Van Bochaute - Astrazeneca
  • 2019-2020: ‘This course gave a very nice overview of the different stakeholders involved in healthcare and on their views. It was also a great network opportunity to meet colleagues from other companies or institutions and it was always great fun.’

    Dagmar Hoeben - Janssen
  • 2019-2020: ‘Very enriching and inspiring course in order to understand the broader picture of our current and future healthcare system. Great opportunity to expand my network within the pharmaceutical industry and to gather relevant insights from experts.’

    Sophie Vandervennet - Janssen
  • 2019-2020: ‘This course is like a drug: once you have taken it, you always want more of it. I really liked the content and the group. Once you start to know each other more, it is even more fun Sometimes I had the impression that we all knew each other already a very long time. So open, so friendly, so interactive…and then surrounded by great organizers in a nice environment Very nice job Dirk & Martine Very happy to be part of the IFB’ers `

    Celine Windels - Abbvie
  • 2019-2020: ‘Must have course, that provides a helicopter view on the different dimensions of health care and excellent network opportunity with other healthcare and pharma stakeholders’

    James De Donder – Sandoz
  • 2019-2020: ‘This course gave me the opportunity to hear the stand point of the different actors in the health care field. I think it’s unique in this way, no other course can offer you this. And this together with meeting new people made it a great experience.’

    Anne Bruneel - Novo Nordisk
  • 2019-2020: ‘Very nice way to extend a professional network / Very interesting topics that gives a perfect view of the pharma sector. Nice to have an online course in these particular times, but we miss the interactions with the presenter and the participant of course’

    Nicolas Vanhee - Amgen
  • 2019-2020: ‘I’m looking forward to attend the other sessions next year very much as I really appreciated the first 2 classes.As mentioned before I’ll be happy then to elaborate more on my experience that was of a great start both for network and diversity of contents.’

    Alexandra Lapeyrere - Gilead
  • 2019-2020: ‘This course offered me the opportunity to share ideas with other colleagues and enabled me to look at evolutions in the pharma sector from different angles. Although the COVID-19 situation disrupted our program, IFB responded immediately with an adapted COVID-19 program. A great example on how to react in our rapidly changing environment ’

    Marjan Willaert - pharma.be
  • 2019-2020: ‘Exhaustive helicopter view of the healthcare system in Belgium. The various courses allowed to have a relevant and insightful overview of the status, the challenges, the future of healthcare and to realize that our domain of work was limited compared to the broader landscape. Furthermore, on a human level, it was rewarding experience, allowing to meet people from different backgrounds and different sectors. There was a lot of respect, listening, opening, interest towards each other and that was a great feeling. Despite our different backgrounds, we felt a lot of goodwill from everybody. It was every month a pleasure to see these 2 days coming …

    Sophie Joubert - MSD
  • ….COVID-19 passed by and the end of the course was a bit special but I am sure we will meet soon in the future and that this experience built a strong and reliable network. To end, the work and implication of Martine, Diane and Dirk should be recognized. We you’re your professionalism but also the respect that the different speakers show to you. That means a lot. THANKS’

    Sophie Joubert - MSD
  • 2019-2020: ‘I was aware that the IFB-virus is a special one. Being infected with it guarantees lifelong immunity to social distancing within the healthcare environment. Thanks for transmitting.’

    Stefaan Vansieleghem - Hebias
  • 2019-2020: ‘This IFB training was a wonderful experience. The atmosphere and team spirit of the group is amazing, I really hope we will all stay connected in the future. The content is extremely interesting, diverse and rich, it is a unique opportunity to better understand and learn more about the pharma world. Of course the COVID-19 situation also brings a unique and memorable touch to this 2019-2020 cursus.’

    Anais Junon - Pfizer
  • 2019-2020: ‘The course gives a nice helicopter view on the Belgian landscape and gives you insights from many different angles and stakeholders. In addition, it gives you a broad network in which participants become colleagues and colleagues become friends.’

    Heleen Vande Capelle - Abbvie
  • 2019-2020: ‘An interesting forum that truly allows for a high-level insight into the complexities and opportunities of the healthcare system in Belgium. Looking forward to applying the knowledge and maintaining the relationships built throughout this course.’

    Christophe Van Elewyck - Gilead
  • 2019-2020: ‘This course is a unique opportunity to learn from the greatest experts in Healthcare and to build an amazing network. It was challenging and fun and worth every second invested in it’

    Vinciane Knappenberg - RIZIV-INAMI
  • 2019-2020: “These monthly sessions have been intellectual holidays providing the opportunity to learn from key experts in lifesciences and expanding your network.”

    Hafida Boufraioua - Inovigate
  • 2019-2020: ‘A great journey in Belgium HC system, showing how much there is that we don’t see, despite we’ve spent years working in the sector. Overall, very well balanced course, devouting time to all concerned stakeholders. I believe it makes people attending the course wiser in a sense that it proves how a complex environment HC is, and how difficult it is to improve it while maintaining the balance.’

    Stefano Losi - Celgene
  • 2019-2020: ‘As a relatively new employee in the pharma sector, this course gave me a great overview of the different faces of it. A lot of food for thought thanks to the very inspiring speakers. It also gave an unique opportunity to build a network with lovely persons having very different roles in the industry.’

    Quentin Haxhe - Abbvie
  • 2019-2020: ‘A journey full of discoveries throughout our healthcare landscape.’

    Olivier Vandecruys - Janssen
  • 2019-2020: ‘A must, whether you are experienced or not in the sector, to have an understanding of the health care sector in Belgium. It is moreover a fantastic network opportunity.’

    Nicolas Istas - Novartis
  • 2019-2020: ‘IFB helps you to broaden your perspective on Belgian healthcare, with a lot of different visions and experiences, and the opportunity to meet a lot of interesting people.’

    Thierry Vanvaerenbergh - Pfizer
  • 2019-2020: ‘Ideal course to get a good overview, and make it possible to connect all the dots in Healthcare. The networking and group discussions were the ‘cherry on the cake’: eye opening and enriching’

    Lisbeth Van Eeckhoudt - Iqvia
  • 2019-2020: ‘A monthly opportunity to connect with a great network while getting a full overview of the healthcare environment of Belgium.’

    Pieter-Jan Mattheus - BMS
  • 2019-2020: ‘Very interesting course for a broad type of audience active in the healthcare sector. For some topics I was even not aware of its existence but now I use these learnings on a daily basis (e.g. specific healthcare apps, https://www.mijngezondheid.belgie.be,.) `

    Andy Vandamme - Novitan
  • 2019-2020: ‘A fantastic course that gives a very good helicopter view of the different stakeholders and evolving trends in the Belgian healthcare. The mix of different functions participating at the course is certainly also an added value. Great networking opportunity.’

    Ann Desmedt - Novartis
  • 2019-2020: ‘IFB takes you on a tour of the Healthcare environment, showing all sides of the industry and all players. A recommendation for everyone working in the Healthcare industry It brings greats amounts of information, insights, connections and opportunities to all. Only by having a common vision can we ensure we work together towards a common sustainable Healthcare system in the future, IFB contributes greatly to this goal.’

    Elke Van Uffel - Iqvia
  • 2018-2019: ´An amazing course with all the elements to become a ’healthcare specialist’. Through networking an unforgettable journey that will last a life time experience´

    Liesbeth Bieghs
  • 2018-2019: ´Great experience with a life long impact & a great new group of friends ´

    Anne-Marie Vanden Broeck
  • 2018-2019: ´Contentoverdracht op hoog niveau door de experten in het desbetreffende health care domein in een aangenaam en vriendschappelijk kader. Mooi overzicht van het health care systeem en de creatie van een uniek netwerk ´

    Els Soete
  • 2018-2019: ´Als boekhouder heb ik een geweldige ervaring opgedaan over de farma wereld ´

    Bruno Heytens
  • 2018-2019: ´Perfect course to get a deep-dive on the healthcare sector, full of interesting insights, surprises and eye-openers. Besides that, it offers you a great opportunity to build your network in the healthcare industry.´

    Wendy Vleugels
  • 2018-2019: ´It was very enriching to meet and hear the whole spectrum of our healthcare system, idea’s and struggles. For me also great to create a new network and look forward to meet them again at the next meeting.´

    Sophie Kerckhove
  • 2018-2019: ´Good to step outside your company/job ‘box’ and get an overarching view on what happens today and tomorrow in Pharma - which you can apply back in your future career. ´

    Sofie Van Hoof
  • 2018-2019: ´A great first insight in the motives of all stakeholders in healthcare ´

    Liesbeth Coenen
  • 2018-2019 : ´17 days of deep-diving into pharma heaving perspectives from different stakeholders, thinking out of the box and networking with great people; and -cherry on the cake- having lot’s of fun Thank you for this great experience. ´

    Eline Van Craeyveld
  • 2018-2019: ´Great opportunity to see the bigger picture after 25 years in clinical operations´

    Marc Janssens
  • 2018-2019: ´Jullie hebben echt een groep van Top Sprekers, blijf dit vooral verder voeden, van sommige sprekers mag het een leveltje hoger (reeds eerder bij specifieke sprekers gevoeld). ´

    Inge Cnudde
  • 2018-2019: ´Unique networking opportunity and educational journey ´

    Pieter Dylst
  • 2018-2019: ´This course gives an excellent and complete overview of our environment. I really recommend this course to colleagues joining our industry from outside pharma. ´

    Dirk Grauwels
  • 2018-2019: `Fantastisch concept om netwerking te bevorderen`

    Colette Fierens
  • 2017-2018 : ´An experience with lifelong impact, every time you meet a participant on an event afterwards, you share this feeling of having experienced something unique and special together.´

    Ellen Vanhaeren
  • 2017-2018 : ´I have experienced this course as being on a real journey taken me to the most remote places of Belgian Healthcare. It was a unique opportunity to build-up and broaden my network in a very informal, fun jet, professional way. I would appreciate to get even more out of my ‘Pharm’ comfort zone to learn on innovative ideas from other industries/out of the box thinking workshops.´

    Isabelle van der Dussen
  • 2017-2018 : ´It was a great course to expand my network within the pharmaceutical industry. It was a great group with incredible team dynamics´

    Susanne Lub
  • 2017-2018 : ´Prachtige inkijk in alle facetten van de farmaceutische industrie.´

    Jo Jansen
  • 2017-2018 : ´Deelnemen aan IFB was een geweldige ervaring. Zo interessant alle stakeholders in healthcare te ontmoeten, zo interessant om te leren hoeveel aspecten aan bod komen vooraleer de patiënt de juiste medicatie kan nemen. Wat beweegt er, wat zijn knelpunten, wat zijn trends, wat zijn opportuniteiten,. leuke groep mensen. Dank ´

    Kristel Smets
  • 2017-2018 : ´After several years in pharma, I appreciated to have the opportunity to reflect on all evolutions in HC. Time to reflect was the most important to me.´

    Anne Gustin
  • 2017-2018: ´Nice to have an overview of the entire healthcare system, summarized into 16 fully packed days. The courses end now, but the network will go on. We will all do our part in keeping the network alive.´

    Marieke Siemons
  • 2017-2018 : ´It’s great to meet different stakeholders from our healthcare environment and understand their needs and get insights in their drive.´

    Caroline Hylebos
  • 2017-2018 : ´Very nice way to connect to peers from other companies and exchange best practices´

    Charlotte Van Bogaert
  • 2017-2018 : ´Eye-opening , exceptional experience that stimulates reflecting on the future as well as on our daily business.´

    Wim Eeraerts
  • 2017-2018 : ´Fascinating journey in the exciting space of pharma. It was a trip that goes much further than I even could have thought to go in my life. Many thanks.´

    Erlend Mazereel
  • 2017-2018 : ´It was an intellectual journey through the current health care landscape to explore opportunities, to face current and future challenges in healthcare with all relevant stakeholders. It was also an excellent network opportunity for me, and I especially enjoyed the social activities at the bar after diner.´

    Dimitri Dehenau
  • 2017-2018 : ´Unforgettable networking journey, compiled with healthcare content.´

    Serge De Ruysscher
  • 2017-2018 : ´Very interesting helicopter-overview course helping you to adopt perspectives from different stakeholders. Besides, a great networking opportunity.´

    Thomas Lettens
  • 2017-2018 : ´A journey through healthcare landscape together with all kin of participants (pharma, authorities) which is a unique possibility.´

    Catherine Traen
  • 2017-2018 : ´I experienced a great educational journey and networking opportunity in a professional, though friendly atmosphere. Thank you ´

    Anke Van Vlerken
  • 2017-2018 : ´Great opportunity to get insights in the most recent evolution in Healthcare, and to network in a `spontaneous` way.´

    Katelijne Butaye
  • 2017-2018 : ´Networking at it`s best´

    Kim Pauwels
  • 2017-2018 : ´IFB is a great opportunity to have an overview of the Belgian healthcare landscape, with the insights of the different stakeholders. In addition, it`s a unique opportunity to build up my network. ´

    Frédérique Voortmans
  • 2017-2018 : ´Geweldige kans om samen te werken en te bouwen aan een sterk netwerk. IFB = incredible network opportunity´

    Peter Van Iperen
  • 2017-2018 : ´For me this was `an intellectual holiday`. Highly refreshing, good work vs network vs fun and and an honor have participated.´

    Jan Bertrand
  • 2017-2018 : ´Heel fijne ervaring Fijne mensen, leuke dynamiek, kritische mensen, super dynamiek. Een unieke gelegenheid waarbij industrie en overheid elkaar kunnen ontmoeten, samenwerken, networken en discussiëren.´

    Veerle Van de Velde
  • 2017-2018 : ´This course was a great way to get a 360° view on the healthcare sector in Belgium, its stakeholders but also its challenges and opportunities.´

    Benjamin Baelus
  • 2017-2018 : ´Un tour d`horizon unique, complet et de grande qualité de l`ensemble de l`environement `santé` et de ses intervernants. Un grand merci.´

    Thierry Vanhandenhove
  • 2016-2017 : ´In deze cursus was netwerking geen opgave maar een spontaan proces.´

    Anouk Waeytens - RIZIV
  • 2016-2017 : ´I think one of the speakers summarised it very well : It was an intellectual holiday.´

    Jean-Christophe Dehalu - APB
  • 2016-2017 : ´It was a educational journey. Thank you for expanding my network.´

    Kevin Van der Auwera – Dr. Falk
  • 2016-2017: ´Zeer aangenaam om de brede kijk op pharma te krijgen.´

    Marianne Donche - Febelco
  • 2016-2017 : ´Great course giving a nice overview of the Belgian healthcare landscape with the benefit of also creating your own network with people from different companies but also hospitals, pharmacists, riziv, kabinet, etc.´

    Sonja Buyle - Gilead
  • 2016-2017: ´De cursus heeft mee een brede kijk gegeven op de farmaceutische industrie, rekening houdend met de verschillende stakeholders. Bovendien was dit een super leuke groep, iets om niet te vergeten en zeker goed voor de toekomst.´

    Roosmarijn De Cock - Bayer
  • 2016-2017: ´IFB offers a unique combination of pharma lecturing and case study, led by leading industry captains. This in combination with practical explanations and reflections from pharma experts.´

    Ines De Maere - TEVA
  • 2016-2017 : ´It’s so interesting to see and learn on all different aspects and stakeholders of our healthcare environment + intersecting and networking with participants/friends by now from all over the environment.´

    Stijn Van Haaren - Abbvie
  • 2016-2017 : ´Great insight into the healthcare system in Belgium, great opportunity to interact with the people at the heart of the system. Great networking opportunity.´

    Nicolas Mathioudakis - Celgene
  • 2016-2017 : ´Fantastic opportunity to meet people from other pharma companies – to exchange idea and brainstorm together. Unique opportunity also to meet key stakeholders in the pharma sector. Martine was speaking the first day about an ‘intellectual holiday’ - totally agree these modules were very instructive – it was my time to reflect and develop my knowledge on the pharma sector.´

    Lena Van Dyck - GSK
  • 2015-2016: ´Interesting as a whole – I would have appreciated more discussion´

    Joost Braakman
  • 2015-2016 : ´Un monde plutôt inconnu pour moi qui est devenu un peu plus connu ´

  • 2015-2016: ´Ik heb een overview gekregen over de gezondheidssector en heb veel toffe en interessante mensen leren kennen´

    Hilde Buelens
  • 2015-2016: ´Je recommande vraiment cette formation à tous ceux qui veulent élargir leur vision du ´secteur pharmaceutique en Belgique et enrichir leur réseau. ´

    Julien Verrax
  • 2015-2016: ´This course will help in the future to think about all kinds of subjects in an innovative way´

    Nele D`Haeze
  • 2015-2016: ´A wonderful and unique opportunity to quickly get an excellent insight into the Belgian pharma landscape and the stakeholders therein´

    Charlotte Weyne
  • 2015-2016: ´Fantastische uitbreiding van mijn netwerk en veel fijne herinneringen´

    Kathleen Commers
  • 2015-2016: ´Fantastische uitbreiding van mijn netwerk en veel fijne herinneringen´

  • 2015-2016: ´It has been a great experience exploring the different parts of the MC system of which I can use a lot in my daily job. I also learned a lot about different companies and stakeholders, through the network with this very varied group of people. It even led to very concrete initiatives on which I’m already working with some IFB colleagues.´

    Tinne Cornelissen
  • 2015-2016: ´Voor iemand zoals ik, zonder veel pharma ervaring, bidet de opleiding een uitstekend zicht op de HealthCare wereld in België´

  • 2015-2016: ´Netwerken +++´

  • 2015-2016: ´Mooi overzicht over de toekomst van de HealthCare´

  • 2015-2016: ´Industry insights combined with a great network´

    Monique Reniers
  • 2015-2016: ´I arrived as a participant and left in a group´

    Pieter Vancaeneghem
  • ´A holiday for the brain, a mental boast and a great opportunity to meet very diverse pharma colleagues and most importantly to learn from them.´

  • ´It has broaden my view on health care in Belgium and I enlarged my network. Very good ‘learning’ experience.´

  • ´Every month, the idea of spending 2 days away from the high workload was frightening but the inspiration & energy I received in return were definitely worth it.´

  • ´As I am new to the pharmaceutical industry, this course gave me a great overview of the industry. I learned a lot but I also got to know great, interesting people´

  • ´One of the presenters referred to the course as an ‘intellectual holiday’ : this was exactly how I experienced it.´

  • ‘IFB was 10 months of learning in combination with Big Fun, perfect match.

  • ´Deze cursus heeft mij cruciale contacten aangeboden om direct de juiste mensen te bereiken binnen het ministerie en daarbuiten´

  • ´Sinds ik een buitenlandse betrekking heb aanvaard, kom ik maandelijks 2 dagen naar België om deel te nemen aan deze cursus´

  • ´Mijn netwerk is door deze cursus enorm gegroeid. Ik heb de mensen, die mijn dossiers behandelen, van dichtbij leren kennen, en begrijp nu beter waar zij belang aan hechten (en waarom).´

  • ´Je n’ai jamais eu le temps pour des activités de réseau. Pendant le cours j’ai pu réaliser personnellement l’importance d networking pour mon entreprise et pour “moi-même”.´

  • ´De gezondheidssector verandert zo snel, dat men zich af vraagt welke weg het op zal gaan. De cursus speelt daar schitterend op in en helpt een goede toekomstvisie te ontwikkelen.´

  • ´Unique opportunity to meet different people in terms of stakeholders, functions, ideas, …This proved to be very inspiring and extremely useful afterwards.´

  • ´De 2 dagen waren steeds zeer intens, maar de flexibiliteit en topsprekers waren steeds een verademing en meer dan waard´

  • ´Cela m’a permis d’avoir une vue complete du secteur et de connaître les notions essentielles pour comprendre d’avantage les dynamiques et les opportunités du secteur. A conseiller vivement´

  • ´Une ouverture unique sur l’ensemble du secteur, dans une atmosphere conviviale.´

  • 2011-2012: `A step stone training course in Biotech/Bio-Pharma business guided by brilliant and knowledgeable speakers with international experience and perspectives. A course I appreciated also due to the highly motivated and interactive class members representing strong experience from all levels of business development.`

    Bjarte Håvik (PhD), Dept. of Clinical Medicine - University Hospital Bergen Norway.
  • 2011-2012: `Perfect approach to cover all dimensions of drug discovery from early stage to post marketing with excellent networking with frontline experts and Flemish and French speaking colleagues in Biotech.`

    Michel Detheux, Director Spin off Project – Ludwig Institute for Cancer Research - Brussels Branch of Human Cancer cell Genetics –ITEOS Therapeutics.
  • 2011-2012: `A Perfect Helicopter view of Biotech Business with World class speakers and great network opportunities.`

    Thibault Helleputte, Spin-Off Project Manager DNAlytics
  • 2011-2012: `A great course covering many aspects of starting and running a biotech company from discovery to reimbursement given by top level speakers in a very open and interactive atmosphere. Highly recommended`

    Marlies De Wouwer, Postdoc Labo Pharmaceutical Biology KULeuven.
  • 2011-2012: `The quality of the audience is just as great as the quality of the speakers. I made very valuable contacts through the network. It is great to have direct access to big names in the different areas linked to product development in a very informal environment.`

    Anny Fortin, Director Research Dafra Pharma R & D.
  • 2011-2012: `A great course. Very informative and ideal for networking.`

    Cédric Ververken, Project Manager Ablynx.
  • 2011-2012: `A very interesting course with speakers that are real experts in their fields. The vivid interactions with the other course attendees and the speakers are very much appreciated.`

    Karine Clauwaert, Licensing Manager VIB
  • 2011-2012: `An extremely enriching course where all top level speakers and participants were clearly passionate about Biotech-Biopharma.`

    Michiel Brutsaert, Sr Medical Advisor Amgen.
  • 2011-2012: `A perfect introduction to the Biotec-Biopharma landscape and challenges. Multi-function approach and insightful presenters make it worth to attend for anybody seeking to improve her/his knowledge of the Biotec-Biopharma industry in Belgium.`

    Eric Lechien, Operational Excellence Europe UCB Pharma S.A.
  • 2011-2012: `Everything you need to know about life in a biotech industry. The mix of high profile speakers in the field, the real life case studies, hands on training and relax atmosphere makes it a very enriching and inspiring experience. Highly recommended.`

    Stéphane Vandendael, Country Manager Genzyme BeLux
  • 2010-2011: `Definitively an unequalled course in this field because high profile speakers are in front of key people involved in life science. Many important issues and items are addressed.`

    Fabrizio Giannotta, CEO Progenosis
  • 2010-2011: `A unique opportunity to meet experts in this field in a very open and interactive way.`

    Frieda Deckers, Clinical Research Director.
  • 2010-2011: `The IFB Masterclass offers a very condensed “crash course” on all aspects of a biotech company, from start to exit, given by top-level highly experienced speakers who provide you with an inside view. This is done in a very informal and relaxed atmosphere with ample network opportunities. Highly recommended`

    Hilde De Winter, TA Head Bone and General Medicine.
  • 2010-2011: `A unique opportunity to get insights in the biotech world presented by key players in the field. A hands-on training in all aspects of spin-off creation to bringing biotech products to the market. `

    Nick Geukens, Research Manager K.U.LEUVEN
  • 2010-2011: `Career enriching experience. Valuable networking. Some of the most brilliant knowledgeable speakers in Biotech/ Pharma.`

    Barbara Leyman, Licensing Manager VIB.
  • 2010-2011: `The training gives a good overview of the biotechnology sector. I’s very important for a Clinical Research Organization to better understand/know what are doing our potential clients. The good atmosphere during this training is a real added value because you even enjoy to go to the training.`

    Julie De Wever, Scientific Partnership Developer Keyrus Biopharma.
  • 2010-2011: `Very stimulating course in an informal atmosphere with a very broad mix of subjects and high profile speakers. Also offers you very good network opportunities.`

    Frank De Smet, Sr. Medical Advisor Landsbond Christelijke Mutualiteiten.
  • 2010-2011: `Following this course was a very enriching experience which allowed me to have a more realistic and clear vision about the broad link between Academia, the industry, and the clinical practice. Also, I greatly appreciate the opportunity to meet several profesisionals and experts of the highest level.`

    Natalia Rueda Rincon, PhD researcher K.U.LEUVEN.
  • 2009-2010: `If Belgium wants to lead in Biotechnology, it also has to lead in “training” Biotechnology. IFB is playing a major role here.`

    Geri Brouwers, General manager META
  • 2009-2010: `A great opportunity to get an understanding of the “life in biotech”, presented by key speakers in the field and flavoured with many real-life examples.`

    Wilfried DALEMANS, CTO and VP Regulatory Affairs TiGenix
  • 2009-2010: ` A unique combination of excellent high-profile speakers, a comprehensive insight in all aspects implicated in biotech business and lots of camaraderie amongst the participants. Highly recommended `

    Chris DE JONGHE, Business Development Manager VIB
  • 2009-2010: `Even if you work in a Biotech company, it is always useful to rediscover your “roots” and to learn of the past to optimize the future of your company. Also the possibility to reflect and discuss with the other participants and faculty members AND the numerous opportunities for Networking make it really worthwhile to follow this course.`

    Hilde STOOP, Managing Director Genzyme
  • 2009-2010: `The biotech world is in full expansion without knowing which forces are crucial for success. That is why it is so important and interesting that this is a very “broad“ course covering topics as legislation, a production site visit, negotiation skills and so much more.No doubt that this course will be essential to become an important player in the “biotech space” in Belgium.`

    Geri Brouwers, General manager and President pharma.be (until February 2010)
  • 2009-2010: `The IFB Masterclass Biotechnology gives you great insight into all aspects of the Biotech Industry. It is a line-up of world-class speakers, a professional organization and a relaxed atmosphere were key to the succes of the first edition of this Masterclass.`

    Joost KOLKMAN, associate Director Ablynx

Copyright © 2024, All rights reserved.